| Identification | More | [Name]
Furaltadone hydrochloride | [CAS]
3759-92-0 | [Synonyms]
5-MORPHOLINOMETHYL-3-[5-NITROFURFURYLIDENEAMINO]-2-OXAZOLIDINONE HYDROCHLORIDE
FURALTADONE HYDROCHLORIDE
LABOTEST-BB LT00244805
5-(morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-2-oxazolidinonmonohyd
5-morpholinomethyl-3-(5-nitrofurfurylidine)amino-2-oxazolidinonehydrochlorid
nf-269
5-(morpholinomethyl)-3-[[(5-nitro-2-furyl)methylene]amino]oxazolidine-2-one hydrochloride
Furmethonol hydrochloride
Nitrofurmethone hydrochloride
FURALTADONEHCLMONOHYDRATE | [EINECS(EC#)]
223-169-4 | [Molecular Formula]
C13H17ClN4O6 | [MDL Number]
MFCD00058201 | [Molecular Weight]
360.75 | [MOL File]
3759-92-0.mol |
| Safety Data | Back Directory | [Hazard Codes ]
Xn | [Risk Statements ]
R22:Harmful if swallowed. | [RIDADR ]
3249 | [WGK Germany ]
3
| [RTECS ]
RQ3630000
| [HazardClass ]
6.1(b) | [PackingGroup ]
III |
| Hazard Information | Back Directory | [Chemical Properties]
Yellow Solid | [Uses]
A metabolite of Nitrofuran in milk. Antibacterial. | [Uses]
Antibacterial;Bacterial DNA damage | [Uses]
Furaltadone Hydrochloride is an antibacterial compound.Environmental contaminants; Food contaminants; Heat processing contaminants | [in vivo]
Furaltadone (3-30 mg/kg, p.o., single dose) reduces the allergic response in IgE-mediated PCA in BALB/c mice by inhibiting mast cell activation and degranulation[3]. | Animal Model: | IgE-mediated passive cutaneous anaphylaxis (PCA) in BALB/c mice[3] | | Dosage: | 3、10、30 mg/kg | | Administration: | Oral gavage (p.o.), single dose | | Result: | Significantly inhibited the allergic response in a dose-dependent manner and reduced mast cell degranulation in the skin. |
|
|
|